Lv1
4 积分 2025-12-20 加入
In vivo chimeric antigen receptor (CAR)-T cell therapy
1个月前
已完结
Large-scale generation of iNK and CAR-iNK cells from CD34+ haematopoietic stem and progenitor cells for adoptive immunotherapy
1个月前
已完结
A second-generation M1-polarized CAR macrophage with antitumor efficacy
1个月前
已完结
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial
1个月前
已完结
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers
1个月前
已完结
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
1个月前
已完结
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
1个月前
已完结
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia
1个月前
已完结
OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours
1个月前
已完结
Immunomodulatory mechanisms of mesenchymal stem cells and their therapeutic applications
2个月前
已完结
皖公网安备34019202002308
